Impax Laboratories to Present at the RBC Capital Markets’ Healthcare Conference
February 24 2012 - 9:30AM
Business Wire
Impax Laboratories, Inc. (NASDAQ: IPXL) today
announced that the Company will present at the RBC Capital Markets’
Healthcare Conference on Wednesday, February 29, at 12:00 p.m. ET.
The conference will be held at The New York Palace Hotel, New York,
NY.
Individuals may listen to the live or an archived presentation
made at the conference, which will be posted in the investor
relations section of the Company’s web site at www.impaxlabs.com.
This presentation will be archived on the Company’s web site for 30
days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing
partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From May 2024 to Jun 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jun 2023 to Jun 2024